NVO
NVO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.
NVO vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% lower-62% |
| PE percentile | 5.4 | 50 | 89% lower-89% |
| EPS | $4.09 | $2.36 | 74% higher+74% |
| FCF | $7.6B | $8.5B | 10% lower-10% |
| Loading historical comparisons… | |||
NVO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Decline |
| Forward profitability | Strongly contracting |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
NVO’s outlook is mixed, with declining sales expectations a concern.
NVO PE Valuation
This table applies NVO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
NVO Earnings Per Share
This chart tracks NVO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
NVO Quarterly Revenue
This chart tracks NVO's quarterly revenue over time and shows how sales are changing from year to year.
NVO Free Cash Flow
This chart tracks NVO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
NVO Total Shares
This chart tracks changes in NVO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
NVO Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
NVO PE vs Healthcare Sector
This chart compares NVO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
NVO Weekly Price
This chart uses NVO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
NVO Weekly Moving Averages
This chart compares NVO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
NVO Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
TMDX
TMDX's valuation is historically cheap, fundamentals provide solid support, but weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.
TMDX vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 21x | 267x | 92% lower-92% |
| PE percentile | 21 | 50 | 58% lower-58% |
| EPS | $3.86 | -$0.06 | $3.92 higher+$3.92 |
| FCF | $79M | -$45.2M | +$124.3M+$124.3M |
| Loading historical comparisons… | |||
TMDX’s earnings are above their historical averages, while its earnings multiple is lower.
TMDX Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Deteriorating |
| Forward earnings | Decline |
| Forward revenue | Strong growth |
| Forward profitability | Stable |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
TMDX’s outlook is mixed, with weaker expected earnings weighing on the picture.
TMDX PE Valuation
This table applies TMDX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
TMDX Earnings Per Share
This chart tracks TMDX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
TMDX Quarterly Revenue
This chart tracks TMDX's quarterly revenue over time and shows how sales are changing from year to year.
TMDX Free Cash Flow
This chart tracks TMDX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
TMDX Total Shares
This chart tracks changes in TMDX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
TMDX Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
TMDX PE vs Healthcare Sector
This chart compares TMDX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
TMDX Weekly Price
This chart uses TMDX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
TMDX Weekly Moving Averages
This chart compares TMDX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
TMDX Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.